|
Q4 FY2026
As of Feb 28, 2026
|
Q4 FY2025
As of Feb 28, 2025
|
|
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | ||
| Accounts receivable, net | ||
| Third Party | ||
| Total accounts receivable, net | ||
| Other current assets | ||
| Deposits, prepayments and other current assets | ||
| Deferred public offering costs | ||
| Advance payment to vendor | ||
| Contract costs | ||
| Total current assets | ||
| Non-current assets: | ||
| Property and equipment, net | ||
| Operating lease right-of-use assets, net | ||
| Prepayments | ||
| Total non-current assets | ||
| TOTAL ASSETS | ||
| LIABILITIES AND SHAREHOLDERS’ (DEFICIT) EQUITY | ||
| Current liabilities: | ||
| Accounts payable | ||
| Accrued liabilities and other payables | ||
| Deferred revenue | ||
| Amount due to director | ||
| Contract liabilities | ||
| Amount due to related parties | ||
| Operating lease liabilities, current | ||
| Loans payable, current | ||
| Total current liabilities | ||
| Non-current liabilities: | ||
| Operating lease liabilities, non-current | ||
| Warrant liabilities | ||
| Total non-current liabilities | ||
| TOTAL LIABILITIES | ||
| SHAREHOLDERS’ (DEFICIT) EQUITY | ||
| Ordinary shares, US$0.001 par value, 50,000,000 shares authorized, 17,500,000 and 21,812,500 shares issued and outstanding as of February 28, 2025 and February 28, 2026 respectively | ||
| Additional paid in capital | ||
| Accumulated deficits | ||
| Total shareholders’ (deficit) equity | ||
| TOTAL LIABILITIES AND SHAREHOLDERS’ (DEFICIT) EQUITY |
Loading...
